SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
SEC Accession No. 0001193125-10-074720
Filing Date
2010-04-01
Accepted
2010-04-01 12:42:48
Documents
13
Group Members
ASTELLAS US HOLDING, INC.RUBY ACQUISITION, INC.

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 7 TO SCHEDULE TO dsctota.htm SC TO-T/A 39332
2 PRESENTATION REGARDING ASTELLAS' OFFER TO ACQUIRE OSI PHARMACEUTICALS dex99a5k.htm EX-99.(A)(5)(K) 224714
3 GRAPHIC g15786exa5ks10gbgd.jpg GRAPHIC 17040
4 GRAPHIC g15786exa5ks11gbgd.jpg GRAPHIC 18440
5 GRAPHIC g15786exa5ks1gbgd.jpg GRAPHIC 5543
6 GRAPHIC g15786exa5ks2gbgd.jpg GRAPHIC 11598
7 GRAPHIC g15786exa5ks3gbgd.jpg GRAPHIC 76004
8 GRAPHIC g15786exa5ks4gbgd.jpg GRAPHIC 45423
9 GRAPHIC g15786exa5ks5gbgd.jpg GRAPHIC 11598
10 GRAPHIC g15786exa5ks6gbgd.jpg GRAPHIC 11598
11 GRAPHIC g15786exa5ks7gbgd.jpg GRAPHIC 41049
12 GRAPHIC g15786exa5ks8gbgd.jpg GRAPHIC 35071
13 GRAPHIC g15786exa5ks9gbgd.jpg GRAPHIC 38627
  Complete submission text file 0001193125-10-074720.txt   697664
Mailing Address 41 PINELAWN ROAD MELVILLE NY 11747
Business Address 41 PINELAWN ROAD MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Subject) CIK: 0000729922 (see all company filings)

IRS No.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A | Act: 34 | File No.: 005-37954 | Film No.: 10722746
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 3-11 NIHONBASHI-HONCHO 2-CHOME CHUO-KU TOKYO M0 103-8411
Business Address 3-11 NIHONBASHI-HONCHO 2-CHOME CHUO-KU TOKYO M0 103-8411 81-3-3244-3231
Astellas Pharma Inc. (Filed by) CIK: 0001376684 (see all company filings)

IRS No.: 132971791
Type: SC TO-T/A